Regulatory Affairs · near · 2026-09-10

The FDA's evidence-grade AI demand creates a regulatory audit constraint

Medical communications is rapidly adopting modular, machine-readable content frameworks and AI models for direct interaction, necessitating stringent controls for compliance. Meanwhile, the FDA is increasingly scrutinizing the 'evidence credibility' of AI outputs, demanding 'evidence-grade' AI with clear regulatory pathways for pharmaceutical submissions. This creates a regulatory audit constraint for AI-driven med comms.